ÂÜÀòÂÒÂ×

John Rimoldi, Ph.D. is Vice President of Paradox, bringing considerable drug synthesis experience to the mission of the company. He is currently Professor of Medicinal Chemistry and Research Professor of the Research Institute of Pharmaceutical Sciences at The University of Mississippi School of Pharmacy and has published over 60 papers and holds multiple patents in the areas of synthetic medicinal chemistry, drug design and development, bioorganic chemistry, and environmental toxicology.

Dr. Rimoldi currently serves as Associate Editor of the Journal of Medicinal Chemistry Letters and is on the Editorial Board of Perspectives in Medicinal Chemistry and The Open Medicinal Chemistry Journal. He is a manuscript reviewer for over 25 journals, has been an active NIH SBIR/STTR grant reviewer since 1998, and serves as a scientific reviewer for the Department of Defense Breast Cancer Research Program. He has received research funding from The National Institutes of Health, Centers for Disease Control and Prevention, US Department of Agriculture, and National Oceanic and Atmospheric Association, American Heart Association, and the American Association of Colleges of Pharmacy. He is Chair of the Section of Chemistry in The American Assoc. of Colleges of Pharmacy, Chair of the Ole Miss Section of the American Chemical Society, and Past-President of the MALTO Medicinal Chemistry organization.

Dr. Rimoldi earned a B.S. in Chemistry from The University of Pittsburgh, and Ph.D. in chemistry from Virginia Tech, followed by post-doctoral training at the Peters Center for the Study of Parkinson’s Disease at Virginia Tech.